We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Controlling Bacteria Without Antibiotics

By Biotechdaily staff writers
Posted on 28 Jun 2005
A method for controlling the activity of bacteria not with the use of antibiotics but by interfering with their communication process has been developed by an Israeli researcher.

Most human and animal diseases are associated with bacteria assembled in communities called biofilms, which attach themselves to the surfaces of live tissues, implants, and teeth. More...
Biofilm can also be found on artificial surfaces such as water pipes and air-conditioning ducts.

Recently, it was discovered that bacteria assembled in biofilms have a network of communication among them called "quorum sensing,” which controls their collective activity or lack of activity. These sensing signals control the physiology and pathogenicity of the bacteria in biofilms. A boron-based molecule produced by these bacteria, called auto inducer-2, controls the signals in this quorum-sensing process.

Dr. Adel Jabbour, of the Hebrew University of Jerusalem (Israel), has succeeded in synthesizing modified chemical compounds, resembling the structure of the natural auto inducer-2, that can disrupt the signaling. By altering the molecular structure in these compounds, Dr. Jabbour was able to show that it is possible to control the quorum sensing responses in order to "deceive” the bacteria. The modified compounds distort the signaling that sets off the bacterial changes, making it possible to seriously hamper the bacterial action, or to enhance it in cases where the bacteria are beneficial.

This control over quorum sensing provides a promising new avenue for the future treatment of bacterial pathogenic activity without having to resort to antibiotic drugs and their accompanying disadvantages. Also, enhancing quorum sensing could prove useful in agriculture, biotechnology, and the food industry, where increasing bacterial activity is sometimes a benefit.

For his work, Dr. Jabbour was presented with a Kaye Innovation Award in June 2005 during the 68th meeting of the Hebrew University Board of Governors.




Related Links:
Hebrew U. of Jerusalem

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.